Head-to-head · Cost-Efficiency Index
Immortals vs Thryve
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Immortals
Cost-first shoppers who want existing Bryan Johnson/Blueprint audience members comfortable prepaying a full quarter upfront for GLP-1s bundled into a broader longevity platform.
Visit ImmortalsThryve
Not currently recommendable — include only for completeness while the underlying site remains this undocumented.
Visit ThryveThe verdict
Immortals takes it, leading the Cost-Efficiency Index 38 to 22. Immortals is the longevity/anti-aging platform from Bryan Johnson and Kate Tolo, offering GLP-1 weight-loss prescribing alongside supplements, biomarker testing, and other prescription verticals. Thryve still earns a C — Not currently recommendable — include only for completeness while the underlying site remains this undocumented.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Immortals.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Immortals | Thryve |
|---|---|---|
| Cost-Efficiency Index | 38/100 | 22/100 |
| Semaglutide / mo | Not disclosed | $99/mo (drug not specified — site never names semaglutide or tirzepatide) |
| Tirzepatide / mo | Not disclosed | $99/mo (drug not specified — site never names semaglutide or tirzepatide) |
| Semaglutide / yr (modeled) | — | $1,188 |
| Tirzepatide / yr (modeled) | — | $1,188 |
| Coverage | Coverage not published | Not disclosed |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #533 | #539 |
Immortals
38/100Where the value is
- High-profile, well-resourced founder brand with strong existing audience trust in the longevity space
- LegitScript badge specifically verifies approval for the immortals.com domain itself
- GLP-1s are bundled with a broader biomarker-testing and supplement ecosystem
The tradeoffs
- Advertised 'per month' pricing is actually a quarterly lump-sum charge paid upfront
- No medical director named on either GLP-1 product page
Thryve
22/100Where the value is
- A low headline price is advertised, if a reader wants to investigate directly
The tradeoffs
- Never names which drug is being sold — no mention of semaglutide, tirzepatide, or any other active ingredient anywhere on the site
- No dose, no state-coverage list, no named clinician, and no named pharmacy found anywhere
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.